COG APAL2020SC - Pediatric Acute Leukemia (PedAL) Screening Trial Developing New Therapies for Relapsed Leukemias


This study aims to use clinical and biological characteristics of acute leukemias to screen for patient eligibility for available pediatric leukemia sub-trials. Testing bone marrow and blood from patients with leukemia that has come back after treatment or is difficult to treat may provide information about the patient's leukemia that is important when deciding how to best treat it, and may help doctors find better ways to diagnose and treat leukemia in children, adolescents, and young adults (0-<22 years old).

I'm interested

Male or Female
Not specified
This study is NOT accepting healthy volunteers
Inclusion Criteria:

• patients must be less than 22 years of age at the time of study enrollment
• participant has known or suspected relapsed/refractory; AML, myeloid leukemia of Down syndrome, B-ALL medullary relapse, T-ALL medullary relapse OR mixed phenotype acute leukemia
• see link to for complete Inclusion criteria


Acute Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia, ALL, Juvenile Myelomonocytic Leukemia

Allison Fullenkamp -
Emily Greengard
See this study on